Michael Stein

Prix à l'honneur

JUVE 2025/2026

Frequently recommended lawyer for Private Equity, especially in the healthcare sector

Michael's clients are primarily financial investors and their portfolio companies as well as strategic investors from Germany and abroad. His practice includes the structuring, negotiation and implementation of complex corporate transactions (buy-side and sell-side, cross-border and domestic), including leveraged buyouts. He has particular expertise in advising on transactions in the highly regulated healthcare sector. Michael is described by his clients as “solution-oriented and pragmatic”. Clients also praise his extensive knowledge of the healthcare sector. He has published a number of articles on corporate law topics in professional journals and regularly lectures on private equity topics. He is co-author of the handbook on medical and healthcare law (Beck'sches Formularbuch Medizin- und Gesundheitsrecht).

Michael Stein is co-head of the German Private Equity practice.

CV

Since 2010 Partner, Taylor Wessing

2001 – 2010 Associate/Counsel, Corporate M&A/Private Equity, Hogan Lovells, Frankfurt am Main and London

Carrière

Since 2010 Partner, Taylor Wessing

2001 – 2010 Associate/Counsel, Corporate M&A/Private Equity, Hogan Lovells, Frankfurt am Main and London

Formation

2001 Admitted and established as a lawyer, Frankfurt am Main

2000 Second state examination, Koblenz

1998 First state examination, Trier

Publications

Steigende Haftungsrisiken für Klinikgeschäftsführung - So stellen Sie rechtzeitig die entscheidenden juristischen Weichen, in: Klinik Management aktuell, Sonderdruck 09/2020, 25. Jg., S. 46-49, gemeinsam mit Christopher Peine

Herausforderungen für M&A-Projekte durch die Corona-Krise: Auswirkungen auf Kaufpreis, Kaufpreisfindung und -sicherung, in: M&A Review, 06/2020, gemeinsam mit Christopher Peine

Der M&A- und Private-Equity-Markt im Life Sciences und Healthcare-Sektor, in: Health&Care Management, 04/2020, gemeinsam mit Christopher Peine

Transaktionen – Veräußerung und Erwerb von Krankenhäusern, Rehabilitations- und Pflegeeinrichtungen (Kapitel J.), in: Scholz/Treptow, Beck’sches Formularbuch Medizin- und Gesundheitsrecht, 1. Auflage 2017, gemeinsam mit Christopher Peine

Die Suche nach dem richtigen Partner – Strukturfragen der Gesundheitsholding, in: HCM Kolumne, 03/2017, gemeinsam mit Christopher Peine

Finanzinvestoren im Gesundheitsmarkt – Transaktionen und Kooperationen als Bestandteil der Investitionsstrategie, in: HCM Kolumne, 01/2017, gemeinsam mit Christopher Peine

Die Verbundlösung - eine Bestandsaufnahme aus rechtlicher Sicht, in: HCM Kolumne, 11/2015 und HCM Ausgabe 1-2/2016, 7. Jg., S. 53, gemeinsam mit Christopher Peine

Unternehmensverkäufe: Exklusiv-Vereinbarungen versus Auktion, in: FYB Financial Yearbook, 12/2014

Kostendruck, knappe Kassen und die Konsolidierung des Marktes Rosige Zeiten für Privatinvestoren im Gesundheitswesen, in: NZS 2011, 525 ff., gemeinsam mit Oliver Klöck

Anmerkung zu BGH-Urteil vom 11.12.2006 – II ZR 243/05, Haftung eines fakultativen Aufsichtsrats einer GmbH, DZWiR 2007, 327 ff.

Anmerkung zu BGH-Urteil vom 16.01.2006 – II ZR 76/04, Kapitalaufbringung bei der GmbH im Rahmen eines sog. Cash-Pool-Systems, DZWiR 2006, 248 ff.

Kapitalerhaltung bei GmbH und AG, DZWiR 2004, 493 ff.

Langues étrangères

Prix et distinctions

JUVE 2025/2026

Featured

Legal 500 2025

The Best Lawyers™ in Germany 2025

Legal 500 2025

Experience

Comprehensive advice to International Chemical Investors Group (ICIG) on M&A transactions

Advising ICIG on various national and international M&A transactions, including the acquisition of Evonik's site in Lülsdorf, near Cologne, and operations in Wesseling.

Press release

Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)

Michael Stein

Hannes Tutt

Dr. Anja Fenge, LL.M.

Dr. Michael Kieffer

Dr. Stefan Horn, LL.B.

NORD Holding and Zentrum Gesundheit on the acquisition of REALEYES Group

The NORD Holding portfolio company Zentrum Gesundheit, the leading ophthalmology group in Lower Saxony, has acquired the majority in REALEYES Group. REALEYES is a market-leading premium provider in the field of ophthalmology in the greater Munich area with over 100 employees at a total of 21 locations. REALEYES offers a wide range of medical treatments in addition to a growing refractive range.

Press release

Michael Stein

Christopher Peine

Nordmed Healthcare GmbH (Medicover Gruppe) on the acquisition of AWO Krankenhaus Calbe

Advised Nordmed Healthcare GmbH (Medicover Group) on the acquisition of AWO Krankenhaus Calbe, a hospital for internal medicine with a geriatric focus. Medicover Group provides integrated and high-quality healthcare services.

Press release

Michael Stein

Christopher Peine

NORD Holding on the acquisition of Zentrum Gesundheit Gruppe

Advised NORD Holding Unternehmensbeteiligungsgesellschaft mbH on the acquisition of a majority interest in Zentrum Gesundheit Group from Waterland Private Equity Investments. Zentrum Gesundheit is a leading German group of eye surgery and diagnostic centers.

Michael Stein

Christopher Peine

Oberberg GmbH on acquisition of Panorama Fachkliniken

Advised Oberberg GmbH on the acquisition of Panorama Fachkliniken (Scheidegg/Allgäu).) As a result of the acquisition, the Berlin-based company's nationwide network will in future be made up of thirteen facilities, making it the leading quality association of private clinics in the field of psychiatry, psychotherapy and psychosomatics in the German-speaking countries.

Press release

Michael Stein

Christopher Peine

The Cadmus Group LLC on the acquisition of ifok and Meister Consultants Group

Advised The Cadmus Group LLC, a leading US strategy consultancy on the acquisition of the consulting companies ifok GmbH and Meister Consultants Group.

Michael Stein

Christopher Peine